Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Two-Compartment Open Model: IV Infusion

Two-Compartment Open Model: IV Infusion

A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

One-Compartment Model: IV Infusion

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Behavioral Genetics and Its Designs

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Expert Recommendations for Rapid Response to Positive Newborn Screen for Infantile Krabbe Disease.

Neurology. Genetics·2026

Same author

<i>COASY</i>-Associated Disorders as a Differential Diagnosis in Cases with Newborn Screening Results Suggestive of CPT-I.

International journal of neonatal screening·2026

Same author

Urine Sorbitol and Xylitol for the Diagnosis of Sorbitol Dehydrogenase Deficiency-Related Neuropathy.

Neurology·2025

Same author

Clinical utility of untargeted urine oligosaccharide screening.

Molecular genetics and metabolism·2025

Same author

High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer.

Frontiers in immunology·2025

Same author

Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2025

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Creating genetics-based infusion centers: a case study of two models.

Dawn J Laney¹, Amy L White, William J Rhead

¹Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.

Genetics in Medicine : Official Journal of the American College of Medical Genetics

|July 22, 2008

Summary

Enzyme replacement therapy (ERT) has expanded since 1993 to treat various genetic lysosomal storage diseases. This has led to specialized genetics infusion centers for comprehensive patient care.

More Related Videos

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Published on: March 21, 2017

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Published on: March 21, 2017

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Area of Science:

Biochemistry
Genetics
Pharmacology

Background:

The first enzyme replacement therapy (ERT) for Gaucher disease was approved in 1993.
Over 13 years, ERT expanded to include treatments for Fabry disease, mucopolysaccharidoses (Types I, II, VI), and glycogen storage disease Type II.
Lysosomal storage diseases (LSDs) are a group of rare genetic disorders.

Observation:

An increasing number of patients with genetic LSDs require regular intravenous ERT.
Genetics teams now play a broader role in managing these patients.
Two outpatient genetics-based infusion centers were developed to manage ERT.

Findings:

The development of ERT has significantly improved treatment options for LSDs.
Outpatient infusion centers streamline the delivery of complex genetic therapies.
These centers facilitate comprehensive care for patients with LSDs.

Implications:

The success of ERT highlights the potential for targeted therapies in genetic diseases.
Specialized infusion centers are crucial for managing the growing number of patients on ERT.
This model of care enhances patient outcomes and supports the evolving role of genetics in medicine.